Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA's Expanded "Access": Definition Includes Drug Coverage And R&D

Executive Summary

PhRMA's public image themes for 2001 will focus on an expanded definition of "access" to include both drug coverage and research incentives.

You may also be interested in...



WTO Patent Declaration Supports Incentives For Rx Companies

The World Trade Organization declaration on pharmaceutical patents includes language encouraging developed countries to provide incentives to industry to improve public health in developing nations

WTO Patent Declaration Supports Incentives For Rx Companies

The World Trade Organization declaration on pharmaceutical patents includes language encouraging developed countries to provide incentives to industry to improve public health in developing nations

AdvancePCS Sees Little Chance For Medicare Rx In 2001

The odds of a Medicare prescription drug benefit becoming law this year are very slim, AdvancePCS CEO David Halbert told the Goldman Sachs healthcare conference in Dana Point, Calif., July 13.

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel